hydrochlorothiazide has been researched along with ibopamine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Kleber, FX; Thyroff-Friesinger, U | 2 |
3 trial(s) available for hydrochlorothiazide and ibopamine
| Article | Year |
|---|---|
[Ibopamine in treatment of mild heart failure, a comparison with hydrochlorothiazide].
Topics: Aged; Cardiotonic Agents; Deoxyepinephrine; Double-Blind Method; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Hydrochlorothiazide; Male | 1991 |
Treatment of mild chronic congestive heart failure with ibopamine, hydrochlorothiazide, ibopamine plus hydrochlorothiazide or placebo. A double-blind comparative study.
Topics: Adult; Aged; Aged, 80 and over; Cardiotonic Agents; Deoxyepinephrine; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Hydrochlorothiazide; Male; Middle Aged; Vasodilator Agents; Water-Electrolyte Balance | 1990 |
Ibopamine versus hydrochlorothiazide/amiloride in patients with mild congestive heart failure. SK & F Ibopamine Working Group.
Topics: Amiloride; Body Weight; Cardiotonic Agents; Deoxyepinephrine; Double-Blind Method; Drug Combinations; Exercise Test; Female; Heart Failure; Humans; Hydrochlorothiazide; Male; Middle Aged; Vasodilator Agents | 1989 |
2 other study(ies) available for hydrochlorothiazide and ibopamine
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |